TIME

The search for the first COVID-19 treatment

WITHIN WEEKS AFTER COVID-19 CASES SPIKED TO ALARMing levels in China, researchers at Gilead in Foster City, Calif., saw an opportunity. A drug the company had developed against Ebola, remdesivir, had shown glimmers of hope in controlling coronaviruses like the one responsible for COVID-19 in the lab. “We knew in the test tube that remdesivir had more activity against coronaviruses like SARS and MERS than against Ebola,” says Dr. Merdad Parsey, chief medical officer of Gilead. After disappointing results in early tests against Ebola, Parsey and his team wondered if remdesivir could turn out to be a better treatment for COVID-19 instead.

Recently, they were rewarded with the first hopeful signs that their hunch might be correct. An international group of researchers reported that in a small study of 53 patients, 68% benefited from

You’re reading a preview, subscribe to read more.

More from TIME

TIME7 min read
Catalysts
It’s been a long time since there was good news about Parkinson’s disease, a neurodegenerative condition that affects more than 8 million people worldwide. But that changed this year, thanks in part to Michael J. Fox’s perseverance in raising awarene
TIME3 min read
Kathleen Hanna
You’ve been in the public eye since you founded your groundbreaking feminist punk band Bikini Kill, over 30 years ago. When did you decide to write your memoir? I started talking about it when I was maybe 40. Then I got sick with Lyme disease, and th
TIME6 min read
A Marriage Of Food And Fiction
Knocking on the front door, it’s already clear that this is one of those dreamy California artist houses, its rich green paint and big windows lighting up a quiet street. Inside there are flowers on the bathroom shelf, music lilting in the background

Related Books & Audiobooks